Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $93.80 USD
Change Today +1.59 / 1.72%
Volume 668.7K
CLVS On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 05/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for clovis oncology inc (CLVS)

Clovis Oncology, Inc. appears to have a strong balance sheet with enough cash in the capital structure to pay down 100% of the liabilities.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Dec 31
2013
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents138.2144.1323.2482.7
Short-Term Investments2.0------
TOTAL CASH AND SHORT TERM INVESTMENTS140.2144.1323.2482.7
Other Receivables--0.43.92.2
TOTAL RECEIVABLES--0.43.92.2
Prepaid Expenses--0.30.52.4
Other Current Assets1.30.11.03.9
TOTAL CURRENT ASSETS141.5144.9328.6491.2
Gross Property Plant and Equipment2.21.61.73.8
Accumulated Depreciation-0.3-0.5-0.7-1.1
NET PROPERTY PLANT AND EQUIPMENT1.91.11.02.7
Goodwill----74.866.1
Deferred Charges, Long Term------8.8
Other Intangibles----244.5212.9
Other Long-Term Assets0.00.00.84.6
TOTAL ASSETS143.4146.0649.6786.2
    
LIABILITIES & EQUITY    
Accounts Payable3.02.34.42.9
Accrued Expenses8.09.916.544.4
Current Income Taxes Payable----0.10.4
TOTAL CURRENT LIABILITIES11.012.221.047.8
Long-Term Debt------287.5
Deferred Tax Liability Non-Current----75.066.9
Other Non-Current Liabilities0.70.355.852.5
TOTAL LIABILITIES11.712.5151.7454.6
Common Stock0.00.00.00.0
Additional Paid in Capital242.2317.9762.2785.1
Retained Earnings-110.5-184.5-269.0-429.0
Comprehensive Income and Other0.00.14.7-24.4
TOTAL COMMON EQUITY131.8133.5497.9331.6
TOTAL EQUITY131.8133.5497.9331.6
TOTAL LIABILITIES AND EQUITY143.4146.0649.6786.2
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLVS:US $93.80 USD +1.59

CLVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for CLVS.
View Industry Companies
 

Industry Analysis

CLVS

Industry Average

Valuation CLVS Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 9.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLOVIS ONCOLOGY INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.